| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K03536150 |
| PharmacoGx | BRD-K03536150 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SYT17 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | ZNF81 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | SPDYE3 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | SLAMF6 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | PRAM1 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | ANKRD26 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | ELL2 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | GATAD2B | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | CIB1 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
| mRNA | FUZ | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
